ODTX
Odyssey Therapeutics, Inc.
18.10$
+0.2%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|
| – | – | – | – | – | |
| – | +0.5% | -2.5% | -7.6% | -10.9% | |
| – | +12.2% | +23.7% | -30.0% | +119.2% | |
| – | – | – | -396.9% | – | |
| – | +249.8% | -96.9% | +410.3% | +25.7% | |
| – | – | – | – | -707.6% | |
| – | – | +0.0% | -31.4% | +91.7% | |
| – | -97.1% | +59,261.5% | -99.6% | +60,263.6% | |
| – | -121.4% | – | -105.3% | – | |
| – | – | – | – | – |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.